{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:34:34Z","timestamp":1779114874993,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s11910-007-0066-7","type":"journal-article","created":{"date-parts":[[2007,9,11]],"date-time":"2007-09-11T04:58:37Z","timestamp":1189486717000},"page":"428-433","source":"Crossref","is-referenced-by-count":73,"title":["Advances in Lafora progressive myoclonus epilepsy"],"prefix":"10.1007","volume":"7","author":[{"given":"Antonio V.","family":"Delgado-Escueta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,12]]},"reference":[{"key":"66_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"B.A. Minassian","year":"1998","unstructured":"Minassian BA, Lee JR, Herbrick JA, et al.: Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 1998, 20:171\u2013174.","journal-title":"Nat Genet"},{"key":"66_CR2","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/oxfordjournals.hmg.a018916","volume":"9","author":"S. Ganesh","year":"2000","unstructured":"Ganesh S, Agarwala KL, Ueda K, et al.: Laforin, defective in progressive myoclonus epilepsy of Lafora type, is a dual specificity phosphatase associated with polyribosomes Hum Mol Genet 2000, 9:2251\u20132261.","journal-title":"Hum Mol Genet"},{"key":"66_CR3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","volume":"35","author":"E.M. Chan","year":"2005","unstructured":"Chan EM, Young EJ, Ianzano L, et al.: Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 2005, 35:125\u2013127.","journal-title":"Nat Genet"},{"key":"66_CR4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/01.WNL.0000133215.65836.03","volume":"63","author":"E.M. Chan","year":"2004","unstructured":"Chan EM, Omer S, Ahmed LR, et al.: Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology 2004, 63:565\u2013567.","journal-title":"Neurology"},{"key":"66_CR5","first-page":"96","volume":"3","author":"G.R. Lafora","year":"1911","unstructured":"Lafora GR, Glueck B: Contribution to the histopathology and pathogenesis of myoclonic epilepsy. Bull Gov Hosp Insane 1911, 3:96\u2013111.","journal-title":"Bull Gov Hosp Insane"},{"key":"66_CR6","first-page":"83","volume":"3","author":"G.R. Lafora","year":"1911","unstructured":"Lafora GR: The presence of amyloid bodies in the protoplasm of the ganglion cells; a contribution to the study of the amyloid substance in the nervous system. Bull Gov Hosp Insane 1911, 3:83\u201392.","journal-title":"Bull Gov Hosp Insane"},{"key":"66_CR7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.1965.00460260062008","volume":"12","author":"G. Schwarz","year":"1965","unstructured":"Schwarz G, Yanoff M: Lafora\u2019s disease. Distinct clinicopathologic form of Unverricht\u2019s syndrome. Arch Neurol 1965, 12:172\u2013188.","journal-title":"Arch Neurol"},{"key":"66_CR8","first-page":"800","volume":"28","author":"G.A. Schwarz","year":"1965","unstructured":"Schwarz GA, Yanoff M: Lafora bodies, corpora amilacea, and Lewy bodies: a morphological and histochemical study. Arch Neurobiol (Madrid) 1965, 28:800\u2013818.","journal-title":"Arch Neurobiol (Madrid)"},{"key":"66_CR9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1528-1157.1993.tb02588.x","volume":"34","author":"J.N. Acharya","year":"1993","unstructured":"Acharya JN, Satischandra P, Asha T, Shankar SK: Lafora\u2019s disease in south India: a clinical, electrophysiologic, and pathologic study. Epilepsia 1993, 34:476\u2013487.","journal-title":"Epilepsia"},{"key":"66_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.20.2.160","volume":"20","author":"M. Sakai","year":"1970","unstructured":"Sakai M, Austin J, Witmer F, et al.: Studies in myoclonus epilepsy (Lafora Body Form) II. Polyglucosans in systemic deposits of myoclonus epilepsy and in corpora amylacea. Neurology 1970, 20:160\u2013176.","journal-title":"Neurology"},{"key":"66_CR11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1212\/WNL.56.12.1739","volume":"56","author":"N. Raben","year":"2001","unstructured":"Raben N, Danon M, Lu N, et al.: Surprises of genetic engineering: a possible model of polyglucosan body disease. Neurology 2001, 56:1739\u20131745.","journal-title":"Neurology"},{"key":"66_CR12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/1531-8249(200004)47:4<536::AID-ANA22>3.0.CO;2-K","volume":"47","author":"F. Ziemssen","year":"2000","unstructured":"Ziemssen F, Sindern E, Schr\u00f6der JM, et al.: Novel missense mutations in the glycogen-branching enzyme gene in adult polyglucosan body disease. Ann Neurol 2000, 47:536\u2013540.","journal-title":"Ann Neurol"},{"key":"66_CR13","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/hmg\/4.9.1657","volume":"4","author":"J.M. Serratosa","year":"1995","unstructured":"Serratosa JM, Delgado-Escueta AV, Posada I, et al.: The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum Mol Gen 1995, 4:1657\u20131663.","journal-title":"Hum Mol Gen"},{"key":"66_CR14","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1086\/301596","volume":"61","author":"J. Sainz","year":"1997","unstructured":"Sainz J, Minassian BA, Serratosa JM, et al.: Lafora progressive myoclonus epilepsy: narrowing the chromosome 6q24 locus by recombinations and homozygosities. Am J Hum Genet 1997, 61:1205\u20131209.","journal-title":"Am J Hum Genet"},{"key":"66_CR15","first-page":"1","volume":"12","author":"S. Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Sakamoto T, et al.: Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 2002, 12:1\u201312.","journal-title":"Hum Mol Genet"},{"key":"66_CR16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/hmg\/ddh130","volume":"13","author":"E.M. Chan","year":"2004","unstructured":"Chan EM, Ackerley CA, Lohi H, et al.: Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum Mol Genet 2004, 13:1117\u20131129.","journal-title":"Hum Mol Genet"},{"key":"66_CR17","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/11.11.1263","volume":"11","author":"S. Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Suzuki T, et al.: Genotype-phenotype correlations for EPM2A mutations in Lafora\u2019s progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum Mol Genet 2002, 11:1263\u20131271.","journal-title":"Hum Mol Genet"},{"key":"66_CR18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.bbrc.2003.12.043","volume":"313","author":"S. Ganesh","year":"2004","unstructured":"Ganesh S, Tsurutani N, Suzuki T, et al.: The carbohydratebinding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem Biophys Res Comm 2004, 313:1101\u20131109.","journal-title":"Biochem Biophys Res Comm"},{"key":"66_CR19","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1093\/hmg\/ddg340","volume":"12","author":"M.E. Fernandez-Sanchez","year":"2003","unstructured":"Fernandez-Sanchez ME, Criado-Garc\u00eda O, Heath KE, et al.: Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum Mol Genet 2003, 12:3161\u20133171.","journal-title":"Hum Mol Genet"},{"key":"66_CR20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2004.10.083","volume":"325","author":"W. Wang","year":"2004","unstructured":"Wang W, Roach PJ: Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase. Biochem Biophys Res Commun 2004, 325:726\u2013730.","journal-title":"Biochem Biophys Res Commun"},{"key":"66_CR21","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1074\/jbc.C100686200","volume":"277","author":"J. Wang","year":"2002","unstructured":"Wang J, Stuckey JA, Wishart MJ, Dixon JE: A unique carbohydrate binding domain targets the Lafora disease phosphatase to glycogen. J Biol Chem 2002, 277:2377\u20132380.","journal-title":"J Biol Chem"},{"key":"66_CR22","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/hmg\/ddg253","volume":"12","author":"S. Ganesh","year":"2003","unstructured":"Ganesh S, Tsurutani T, Suzuki T, et al.: The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain. Hum Mol Gen 2003, 12:2359\u20132368.","journal-title":"Hum Mol Gen"},{"key":"66_CR23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0888-7543(03)00094-6","volume":"81","author":"L. Ianzano","year":"2003","unstructured":"Ianzano L, Zhao XC, Minassian BA, Scherer SW: Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 2003, 81:579\u2013587.","journal-title":"Genomics"},{"key":"66_CR24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0014-5793(96)01357-9","volume":"399","author":"M.J. Doherty","year":"1996","unstructured":"Doherty MJ, Young PR, Cohen PT: Amino acid sequence of a novel protein phosphatase 1 binding protein (R5) which is related to the liver-and muscle-specific glycogen binding subunits of protein phosphatase 1. FEBS Lett 1996, 399:339\u2013343.","journal-title":"FEBS Lett"},{"key":"66_CR25","doi-asserted-by":"crossref","unstructured":"Singh S, Sethi I, Francheschetti S, et al.: Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora\u2019s progressive myoclonus epilepsy. Am J Med Genet 2007, In press.","DOI":"10.1136\/jmg.2005.039479"},{"key":"66_CR26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"64","author":"C. Gomez-Abad","year":"2005","unstructured":"Gomez-Abad C, Gomez-Garre P, Gutierrez-Delicado E, et al.: Lafora disease due to EPM2B mutations: a clinical and genetic study. Neurology 2005, 64:982\u2013986.","journal-title":"Neurology"},{"key":"66_CR27","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","volume":"102","author":"M.S. Gentry","year":"2005","unstructured":"Gentry MS, Worby CA, Dixon JE: Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci U S A 2005, 102:8501\u20138506.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"66_CR28","unstructured":"Machado-Salas J, Bai D, Avila MR, et al.: Lafora disease: a disorder of protein degradation and clearance? Paper presented at the American Academy of Neurology. San Francisco, CA; April, 2004."},{"key":"66_CR29","unstructured":"Machado-Salas J, Avila MR, Yamakawa K, et al.: Cell death in transgenic mice model of Lafora disease. Paper presented at the American Neurological Association Annual Meeting. San Francisco, CA; October, 2003."},{"key":"66_CR30","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","volume":"14","author":"H. Lohi","year":"2005","unstructured":"Lohi H, Ianzano L, Zhao XC, et al.: Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 2005, 14:2727\u20132736.","journal-title":"Hum Mol Genet"},{"key":"66_CR31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0887-8994(00)00276-9","volume":"25","author":"B.A. Minassian","year":"2001","unstructured":"Minassian BA: Lafora\u2019s disease: towards a clinical, pathologic and molecular synthesis. Pediatr Neurrol 2001, 25:21\u201329.","journal-title":"Pediatr Neurrol"},{"key":"66_CR32","doi-asserted-by":"crossref","first-page":"11815","DOI":"10.1074\/jbc.M600519200","volume":"281","author":"T. Niityla","year":"2006","unstructured":"Niityla T, Comparot-Moss S, Lue WL, et al.: Similar protein phosphatases control starch metabolism in plants and glycogen metabolism in mammals. J Biol Chem 2006, 281:11815\u201311818.","journal-title":"J Biol Chem"},{"key":"66_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ajmg.1575","volume":"106","author":"A.V. Delgado-Escueta","year":"2001","unstructured":"Delgado-Escueta AV, Ganesh S, Yamakawa K: Advances in the genetics of progressive myoclonus epilepsy. Am J Med Genet 2001, 106:129\u2013138.","journal-title":"Am J Med Genet"},{"key":"66_CR34","first-page":"486","volume":"65","author":"N. Raben","year":"1999","unstructured":"Raben N, Nagaraju K, Lee E, Plotz P: Increased glycogen load accelerates the course of the disease in the acid alphaglucosidase knockout mice. Am J Hum Genet 1999, 65:486.","journal-title":"Am J Hum Genet"},{"key":"66_CR35","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(97)00069-7","volume":"29","author":"M. Kyllerman","year":"1998","unstructured":"Kyllerman M, Ben-Menachem E: Zonizamide for progressive myoclonus epilepsy: long term observations in seven patients. Epilepsy Res 1998, 29:109\u2013114.","journal-title":"Epilepsy Res"},{"key":"66_CR36","first-page":"47","volume":"95","author":"E.M. Chan","year":"2005","unstructured":"Chan EM, Andrade DM, Franceschetti S, et al.: Progressive myoclonus epilepsy: EPM1, EPM2A, EPM2B in myoclonic epilepsies. Adv Neurol 2005, 95:47\u201358.","journal-title":"Adv Neurol"},{"key":"66_CR37","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1073\/pnas.130187497","volume":"97","author":"N. Shi","year":"2000","unstructured":"Shi N, Pardridge WM: Noninvasive gene targeting to the brain. Proc Natl Acad Sci U S A 2000, 97:7567\u20137572.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0066-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-007-0066-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-007-0066-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:24:38Z","timestamp":1559420678000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-007-0066-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["66"],"URL":"https:\/\/doi.org\/10.1007\/s11910-007-0066-7","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}